Valeant Pharmaceuticals CEO Pearson Schedules Investor Update For The Ides Of March |
| March 08, 2016 | March 2016 Bond Updates |
|
Valeant plans to update investors on its fourth quarter results and provide new 2016 guidance. This meeting, scheduled for 8 a.m ET on March 15, is sure to be a pivotal moment for CEO Michael Pearson. |
| View more at: http://www.forbes.com/sites/antoinegara/2016/03/07/valeant-pharmaceuticals-ceo-pearson-schedules-investor-update-for-the-ides-of-march/ |
| Related News |